Discover a study exploring how AI can transform allergy and immunology, highlighting challenges, opportunities, and a roadmap ...

Catalytic antibodies represent a unique class of immunoglobulins that combine conventional antigen recognition with intrinsic enzymatic activity, facilitating the direct cleavage of specific molecular ...

When Robert Kennedy Jr. announced the cancellation of 22 projects related to mRNA vaccines and the end of new investments in ...

HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases HiFiBiO Therapeutics, a ...

O3R-5671 is designed to overcome the limitations of first-generation SIK inhibitors, providing a potential new oral treatment option for multiple ...

(RTTNews) - Bristol Myers Squibb (BMY) and Bain Capital have announced the formation of a new independent biopharmaceutical company dedicated to developing innovative therapies for autoimmune diseases ...

The news that the brand is protected from generics for more than a decade "gives AbbVie a kind of tremendous runway," to sell ...

AbbVie (NYSE:ABBV) announced on Thursday that the company has reached settlements with all generic drugmakers to resolve ...

Penn Medicine recently unveiled an eight-floor immunology research center in a $376 million expansion to an existing office ...

Default PDA instrument method settings are frequently used for routine HPLC analysis. While these default settings are often suitable, they may need to be modified to obtain optimal separations. In ...

July 28 (Reuters) - Drugmaker Bristol Myers Squibb (BMY.N), opens new tab and private equity firm Bain Capital will launch an independent company focused on developing immunology drugs, backed by Bain ...